Stockreport

Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In? [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF that the first patient had been dosed in one of three expansion cohorts in the Phase 1 trial evaluating VIR-5500, a prostate-specific membrane antigen (PSMA)-targeted, P [Read more]